Interleukin-22 and Tumor Necrosis Factor Receptor Associated Factor 1 (TRAF1) in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus: Correlation with Disease Activity - Egyptian Knowledge Bank

4476

Interleukin-22 and Tumor Necrosis Factor Receptor Associated Factor 1 (TRAF1) in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus: Correlation with Disease Activity

Article

Last updated: 22 Jan 2023

Overview Similar Items

Article

Pathogenic Role of Interlukin-23(IL-23) in Rheumatoid Arthritis Patients; its Relation to Disease Activity

Article

Serum Interleukin-33 in Rheumatoid Arthritis and its Relation to Disease Activity

Article

Interleukin-10, Interleukin- 16 and Interferon-γ in serum of patients with rheumatoid arthritis and correlation with disease activity

Article

Serum Levels Of Interleukin–12 And Tumour Necrosis Factor– In Patients With Active And Inactive Rheumatoid Arthritis

Article

Interleukin-33 as a marker for disease activity in rheumatoid arthritis

Article

Association between Interleukin-21 Serum Level and IL-21 Genetic Polymorphism with the Cardiovascular Morbidity Risk in Rheumatoid Arthritis and Systemic Lupus Erythematosus Pati

Article

Sirtuin-1 in Rheumatoid Arthritis Patients, Relation to Disease Activity and Interleukin-17A

Article

The Use of Interleukin-22 as a Novel Marker of Disease Activity in Female Patients with Rheumatoid Arthritis

Article

Serum Interleukin-17 Level in Patients with Rheumatoid Arthritis and its Relation to Disease Activity

Article

Serum interleukin 29 in Rheumatoid Arthritis and Systemic Lupus Erythematosus patients and its association with disease activity.